CA-GLOBALPLATFORM
24.5.2023 08:01:30 CEST | Business Wire | Press release
GlobalPlatform, a leading digital standards organization, has launched a broad-reaching initiative to drive engagement across security experts in the full automotive value chain and adjacent digital services. As a leader in delivering specifications and certifications for secure digital services — over 70 billion GlobalPlatform secure components deployed worldwide —GlobalPlatform is now addressing emerging automotive regulations such as new vehicle type approvals and the shift towards vehicles as a service. GlobalPlatform’s automotive initiative will optimize and accelerate the deployment of secure components, trusted digital architecture, security APIs, and security lifecycle management within the automotive sector. This initiative is being led by a dedicated Automotive Task Force to foster the alignment of GlobalPlatform technologies with automotive use cases. GlobalPlatform has also partnered with automotive standards organizations and formed the Cybersecurity Vehicle Forum to unite the automotive ecosystem in optimizing cybersecurity for vehicles.
“Recent automotive cybersecurity regulations and emerging trends like the move towards autonomous driving and flexible mobility solutions are requiring car manufacturers to become more agile and adaptable in the deployment of secure vehicle services. GlobalPlatform’s secure component technologies support the automotive sector’s compliance with these new regulations and requirements,” said Ana Tavares Lattibeaudiere, Executive Director, GlobalPlatform.
In addition to launching the Automotive Task Force, GlobalPlatform established a cooperative agreement with the Society of Automotive Engineers (SAE) to work on the harmonization of hardware-based secure execution environments in automotive. GlobalPlatform has also partnered with AUTOSAR to coordinate the alignment of secure component standards and specifications for automotive. Furthermore, GlobalPlatform has joined the Auto-ISAC community and has an active memorandum of understanding (MoU) with the Car Connectivity Consortium. These alliances will ensure coordination and alignment on common requirements with key automotive and cybersecurity organizations.
“GlobalPlatform is committed to working with the full automotive value chain to address current automotive security requirements while also focusing on developing interoperable, secure components to meet emerging vehicle standards,” said Gil Bernabeu, Chief Technology Officer, GlobalPlatform.
Another key aspect of GlobalPlatform’s automotive initiative is the launch of the Cybersecurity Vehicle Forum, which will strengthen engagement and cooperation between GlobalPlatform members and the wider automotive ecosystem. The Forum plays an invaluable role in identifying and prioritizing automotive industry requirements to deliver secure component services that span the lifecycle of a vehicle. With global events planned throughout the year, the Cybersecurity Vehicle Forum gives car manufacturers, component companies, automotive regulators, and others a platform to explore the current and future automotive use cases for trusted services and hardware-based secure services.
GlobalPlatform welcomes existing and new member contributions in developing the next generation of automotive security standards and invites the automotive ecosystem to participate in the Cybersecurity Vehicle Forum.
Contact automotive@globalplatform.org to learn more.
About GlobalPlatform
GlobalPlatform is a technical standards organization that enables the efficient launch and management of innovative, secure-by-design digital services and devices, which deliver end-to-end security, privacy, simplicity, and convenience to users. It achieves this by providing standardized technologies and certifications that empower technology and service providers to develop, certify, deploy, and manage digital services and devices in line with their business, security, regulatory and data protection needs. GlobalPlatform technologies are used in billions of smart cards, smartphones, wearables and other connected IoT devices.
GlobalPlatform standardized technologies and certifications are developed through effective industry-driven collaboration, led by multiple diverse member companies working in partnership with industry and regulatory bodies and other interested parties from around the world.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005955/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom